Blackstone Inc’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-52,343
| Closed | -$2.04K | – | 193 |
|
|
2024
Q3 | $2.04K | Hold |
52,343
| – | – | ﹤0.01% | 157 |
|
|
2024
Q2 | $15.2K | Hold |
52,343
| – | – | ﹤0.01% | 169 |
|
|
2024
Q1 | $753K | Hold |
52,343
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $612K | Hold |
52,343
| – | – | ﹤0.01% | 126 |
|
|
2023
Q3 | $785K | Hold |
52,343
| – | – | ﹤0.01% | 122 |
|
|
2023
Q2 | $1.09M | Hold |
52,343
| – | – | ﹤0.01% | 119 |
|
|
2023
Q1 | $462K | Hold |
52,343
| – | – | ﹤0.01% | 137 |
|
|
2022
Q4 | $560K | Hold |
52,343
| – | – | ﹤0.01% | 122 |
|
|
2022
Q3 | $749K | Hold |
52,343
| – | – | ﹤0.01% | 137 |
|
|
2022
Q2 | $1.86M | Hold |
52,343
| – | – | 0.01% | 125 |
|
|
2022
Q1 | $5.25M | Hold |
52,343
| – | – | 0.01% | 132 |
|
|
2021
Q4 | $7.8M | Hold |
52,343
| – | – | 0.02% | 153 |
|
|
2021
Q3 | $18.4M | Buy |
+52,343
| New | +$18.4M | 0.04% | 108 |
|
|
2021
Q2 | – | Sell |
-12,000
| Closed | -$2.93M | – | 661 |
|
|
2021
Q1 | $2.93M | Buy |
+12,000
| New | +$2.93M | 0.01% | 275 |
|